AMNEAL PHARMACEUTICALS, INC. Finance Lease, Liability, to be Paid, Year One
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Finance Lease, Liability, to be Paid, Year One of $7.58 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-02-27
- 2025-12-31: Finance Lease, Liability, to be Paid, Year One $7.58M.
- 2024-12-31: Finance Lease, Liability, to be Paid, Year One $7.51M.
- 2023-12-31: Finance Lease, Liability, to be Paid, Year One $6.86M.
- 2022-12-31: Finance Lease, Liability, to be Paid, Year One $7.98M.
| Period end | Finance Lease, Liability, to be Paid, Year One | Finance Lease, Liability, to be Paid, Year One as first filed |
|---|---|---|
| 2025-12-31 | $7.58M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $7.51M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $6.86M 10-K · filed 2025-02-28 | |
| 2022-12-31 | $7.98M 10-K · filed 2024-03-14 | |
| 2021-12-31 | $7.49M 10-K · filed 2023-03-03 | |
| 2020-12-31 | $7.43M 10-K · filed 2022-03-01 | $5.47M 10-K · filed 2021-03-01 |
| 2019-12-31 | $5.47M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |